134
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Immunomodulatory effect of vitamin D supplementation on Behçet’s disease patients: effect on nitric oxide and Th17/Treg cytokines production

, , , &
Pages 1-10 | Received 18 Nov 2022, Accepted 17 Jul 2023, Published online: 03 Aug 2023

References

  • Hatemi G, Seyahi E, Fresko I, et al. One year in review 2020: behçet’s syndrome. Clin Exp Rheumatol. 2020;127(38 Suppl):3–10.
  • Bettiol A, Prisco D, Emmi G. Behçet: the syndrome. Rheumatology (Oxford). 2020;59(Suppl 3):iii101–iii107. doi:10.1093/rheumatology/kez626.
  • Djeraba Z, Benlabidi F, Djaballah-Ider FZ, et al. Vitamin D status in algerian behçet’s disease patients: an immunomodulatory effect on NO pathway. Immunopharmacol Immunotoxicol. 2017;39(4):243–250. doi:10.1080/08923973.2017.1327967.
  • Rafa H, Abdelouaheb K, Belkhelfa M, et al. PS1-01 nitric oxide modulation by retinoic acid, IL-17A and TNF-α in PBMC and colonic mucosa cultures from algerian patients with inflammatory bowel disease. Cytokine. 2010;52(1-2):17. doi:10.1016/j.cyto.2010.07.073.
  • Arroul-Lammali A, Djeraba Z, Belkhelfa M, et al. Early involvement of nitric oxide in mechanisms of pathogenesis of experimental autoimmune uveitis induced by interphotoreceptor retinoid-binding protein (IRBP). J Fr Ophtalmol. 2012;35(4):251–259. doi:10.1016/j.jfo.2011.05.003.
  • Le Joncour A, Martos R, Loyau S, et al. Critical role of neutrophil extracellular traps (NETs) in patients with behcet’s disease. Ann Rheum Dis. 2019;78(9):1274–1282. doi:10.1136/annrheumdis-2018-214335.
  • Xue Q, Yan Y, Zhang R, et al. Regulation of iNOS on immune cells and its role in diseases. Int J Mol Sci. 2018;19:3805. doi:10.3390/ijms19123805.
  • Yan J-B, Luo M-M, Chen Z-Y, et al. The function and role of the Th17/treg cell balance in inflammatory bowel disease. J Immunol Res. 2020;2020:8813558. doi:10.1155/2020/8813558.
  • Hamzaoui K, Bouali E, Ghorbel I, et al. Expression of Th-17 and RORγt mRNA in behçet’s disease. Med Sci Monit. 2011;17(4):CR227–234. doi:10.12659/msm.881720.
  • Berry S-G, Dossou C, Kashif A, et al. The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases. Int Immunopharmacol. 2022;102:108402. doi:10.1016/j.intimp.2021.108402.
  • Li Z, Li D, Tsun A, et al. FOXP3+ regulatory T cells and their functional regulation. Cell Mol Immunol. 2015;12(5):558–565. doi:10.1038/cmi.2015.10.
  • Grover P, Goel PN, Greene MI. Regulatory T cells: regulation of identity and function. Front Immunol. 2021;12:750542. doi:10.3389/fimmu.2021.750542.
  • Abbasian S, Soltani-Zangbar MS, Khabbazi A, et al. Nanocurcumin supplementation ameliorates behcet’s disease by modulating regulatory T cells: a randomized, double‐blind, placebo‐controlled trial. Int Immunopharmacol. 2021;101(Pt B):108237. doi:10.1016/j.intimp.2021.108237.
  • Albayrak O, Oray M, Can F, et al. Effect of interferon alfa-2a treatment on adaptive and innate immune systems in patients with behçet disease uveitis. Invest. Ophthalmol. Vis. Sci. 2019;60(1):52–63. doi:10.1167/iovs.18-25548.
  • Zou J, Thornton C, Chambers ES, et al. Exploring the evidence for an immunomodulatory role of vitamin D in juvenile and adult rheumatic disease. Front Immunol. 2020;11:616483.
  • Athanassiou L, Mavragani CP, Koutsilieris M. The immunomodulatory properties of vitamin D. MJR. 2022;33(1):7–13. doi:10.31138/mjr.33.1.7.
  • Carlberg C, Seuter S, Heikkinen S. The first genome-wide view of vitamin D receptor locations and their mechanistic implications. ANTICANCER Res. 2012;12:271–282.
  • Bettencourt A, Boleixa D, Reguengo H, et al. Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the North of Portugal. J Steroid Biochem Mol Biol. 2018;180:137–141. doi:10.1016/j.jsbmb.2017.09.016.
  • Sukharani N, Dev K, Rahul F, et al. Association between rheumatoid arthritis and serum vitamin D levels. Cureus [Internet]. 2021;
  • Hlavaty T, Krajcovicova A, Payer J. Vitamin D therapy in inflammatory bowel diseases: who, in. What Form, and How Much? J Crohns Colitis. 2015;9(2):198–209. doi:10.1093/ecco-jcc/jju004.
  • Gonçalves Zorzella-Pezavento S, Nishiyama Mimura L, Denadai M, et al. Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis? Neural Regen Res. 2022;17:1945.
  • Vernia F, Valvano M, Longo S, et al. Vitamin D in inflammatory bowel diseases. Mechanisms of Action and Therapeutic Implications. Nutrients. 2022;14:269.
  • Postlethwaite AE, Tuckey RC, Kim T-K, et al. 20S-Hydroxyvitamin D3, a secosteroid produced in humans, is anti-Inflammatory and inhibits murine autoimmune arthritis. Front. Immunol. 2021;12:678487. doi:10.3389/fimmu.2021.678487.
  • Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, et al. The status of serum vitamin D in patients with active behcet’s disease compared with controls. Int J Rheum Dis. 2014;17(4):430–434. doi:10.1111/1756-185X.12153.
  • Aslan N, Demirci K, Güler T, et al. The effect of vitamin D on clinical manifestations and activity of behçet’s disease. pdia. 2017;1:15–20. doi:10.5114/pdia.2016.57222.
  • Hamzaoui K, Ben Dhifallah I, Karray E, et al. Vitamin D modulates peripheral immunity in patients with behçet’s disease. Clin Exp Rheumatol. 2010;28: s50–57.
  • Criteria for diagnosis of behcet’s disease. International study group for Behçet’s disease. The Lancet. 1990;335(8697):1078–1080.
  • Kang H. Sample size determination and power analysis using the G*power software. J Educ Eval Health Prof. 2021;18:17. doi:10.3352/jeehp.2021.18.17.
  • Abdel-Wareth L, Haq A, Turner A, et al. Total vitamin D assay comparison of the roche diagnostics “vitamin D total” electrochemiluminescence protein binding assay with the chromsystems HPLC method in a population with both D2 and D3 forms of vitamin D. Nutrients. 2013;5(3):971–980. doi:10.3390/nu5030971.
  • Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85(8):752–758. doi:10.4065/mcp.2010.0138.
  • Touil-Boukoffa C, Bauvois B, Sancéau J, et al. Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-γ levels. Biochimie. 1998;80(8-9):739–744.
  • Zhao R, Zhang W, Ma C, et al. Immunomodulatory function of vitamin D and its role in autoimmune thyroid disease. Front Immunol. 2021;12:574967.
  • Bahlous A, Krir A, Mrad M, et al. Vitamin D in healthy tunisian population: preliminary results. J Med Biochemistry. 2022;41(2):168–175. doi:10.5937/jomb0-30247.
  • Tomei S, Singh P, Mathew R, et al. The role of polymorphisms in vitamin D-Related genes in response to vitamin D supplementation. Nutrients. 2020;12(9):2608. doi:10.3390/nu12092608.
  • Das UN. Pro- and anti-inflammatory bioactive lipids imbalance contributes to the pathobiology of autoimmune diseases. Eur J Clin Nutr [Internet]. 2022;77(6):637–651.
  • Ammar M, Heni S, Tira MS, et al. Variability in response to vitamin D supplementation according to vitamin D metabolism related gene polymorphisms in healthy adults. Eur J Clin Nutr. 2023;77(2):189–194.
  • Karatay S, Yildirim K, Karakuzu A, et al. Vitamin D status in patients with behcet’s disease. Clinics. 2011;66:721–723.
  • Zhong Z, Su G, Du L, et al. Higher 25-hydroxyvitamin D level is associated with increased risk for behçet’s disease. Clin Nutr Edinb Scotl. 2021;40(2):518–524. doi:10.1016/j.clnu.2020.05.049.
  • Turrubiates‑Hernández FJ, Sánchez‑Zuno GA, González‑Estevez G, et al. Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: an ally for latin america (review). Int J Mol Med. 2021;47(4):1–1. doi:10.3892/ijmm.2021.4865.
  • Wink DA, Hanbauer I, Grisham MB, et al. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr Top Cell Regul. 1996;34:159–187.
  • Peranzoni E, Marigo I, Dolcetti L, et al. Role of arginine metabolism in immunity and immunopathology. Immunobiology. 2008;212(9-10):795–812. doi:10.1016/j.imbio.2007.09.008.
  • Cartwright ANR, Suo S, Badrinath S, et al. Immunosuppressive myeloid cells induce nitric oxide-dependent DNA damage and p53 pathway activation in CD8+ T cells. Cancer Immunol Res. 2021;9(4):470–485. doi:10.1158/2326-6066.CIR-20-0085.
  • Omar HS, Taha FM, Fouad S, et al. The association between vitamin D levels and oxidative stress markers in egyptian behcet’s disease patients. Orphanet J Rare Dis. 2022;17(1):264. doi:10.1186/s13023-022-02416-4.
  • Choi B, Lee E-S, Sohn S. Vitamin D3 ameliorates herpes simplex virus-induced behçet’s disease-like inflammation in a mouse model through down-regulation of toll-like receptors. Clin Exp Rheumatol. 2011;29: s13–19.
  • Fernandez GJ, Ramírez-Mejía JM, Urcuqui-Inchima S. Vitamin D boosts immune response of macrophages through a regulatory network of microRNAs and mRNAs. J Nutr Biochem. 2022;109:109105. doi:10.1016/j.jnutbio.2022.109105.
  • Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723–737. doi:10.1038/nri3073.
  • Bishop L, Ismailova E, Dimeloe A, et al. Vitamin D and immune regulation: antibacterial, antiviral, anti-Inflammatory. JBMR Plus. 2021;5(1):e10405. doi:10.1002/jbm4.10405.
  • Mansournia MA, Ostadmohammadi V, Doosti-Irani A, et al. The effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress in diabetic patients: a systematic review and Meta-Analysis of randomized controlled trials. Horm Metab Res Horm Stoffwechselforschung Horm Metab. 2018;50:429–440.
  • Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12: e988. doi:10.3390/nu12040988.
  • Barchetta I, Cimini FA, Cavallo MG. Vitamin D and metabolic Dysfunction-Associated fatty liver disease (MAFLD): an update. Nutrients. 2020;12: e3302. doi:10.3390/nu12113302.
  • Pierrot-Deseilligny C, Souberbielle J-C. Vitamin D and multiple sclerosis: an update. Mult Scler Relat Disord. 2017;14:35–45. doi:10.1016/j.msard.2017.03.014.
  • Harrison SR, Li D, Jeffery LE, et al. Vitamin D, autoimmune disease and rheumatoid arthritis. Calcif Tissue Int. 2020;106(1):58–75. doi:10.1007/s00223-019-00577-2.
  • Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. 2020;12:2097. doi:10.3390/nu12072097.
  • Sîrbe C, Rednic S, Grama A, et al. An update on the effects of vitamin D on the immune system and autoimmune diseases. IJMS. 2022;23(17):9784. doi:10.3390/ijms23179784.
  • Zhou L, Wang J, Li J, et al. 1,25-Dihydroxyvitamin D3 ameliorates Collagen-Induced arthritis via suppression of Th17 cells through miR-124 mediated inhibition of IL-6 signaling. Front Immunol. 2019;10:178. doi:10.3389/fimmu.2019.00178.
  • Dankers W, Davelaar N, van Hamburg JP, et al. Human memory Th17 cell populations change into anti-inflammatory cells with regulatory capacity upon exposure to active vitamin D. Front Immunol. 2019;10:1504. doi:10.3389/fimmu.2019.01504.
  • Xu A, Liu Y, Chen W, et al. TGF-β-Induced regulatory T cells directly suppress B cell responses through a noncytotoxic mechanism. J Immunol. 2016;196(9):3631–3641. doi:10.4049/jimmunol.1501740.
  • Dong C. Cytokine regulation and function in T cells. Annu Rev Immunol. 2021;39:51–76. doi:10.1146/annurev-immunol-061020-053702.
  • Mesquida M, Leszczynska A, Llorenç V, et al. Interleukin-6 blockade in ocular inflammatory diseases. Clin Exp Immunol. 2014;176(3):301–309. doi:10.1111/cei.12295.
  • Geri G, Terrier B, Rosenzwajg M, et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in behçet disease. J Allergy Clin Immunol. 2011;128(3):655–664. doi:10.1016/j.jaci.2011.05.029.
  • Shen H, Xia L, Lu J. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with behçet’s disease. Scand J Rheumatol. 2013;42(1):48–51. doi:10.3109/03009742.2012.704391.
  • Goda S, Hayakawa S, Karakawa S, et al. Possible involvement of regulatory T cell abnormalities and variational usage of TCR repertoire in children with autoimmune neutropenia. Clin Exp Immunol. 2021;204(1):1–13. doi:10.1111/cei.13559.
  • Semple JW, Rebetz J, Maouia A, et al. An update on the pathophysiology of immune thrombocytopenia. Curr Opin Hematol. 2020;27(6):423–429. doi:10.1097/MOH.0000000000000612.
  • Qin Y, Gao C, Luo J. Metabolism characteristics of Th17 and regulatory T cells in autoimmune diseases. Front Immunol. 2022;13:828191. doi:10.3389/fimmu.2022.828191.
  • Filleron A, Tran TA, Hubert A, et al. Regulatory T cell/Th17 balance in the pathogenesis of paediatric behçet disease. Rheumatology. 2021;61(1):422–429. doi:10.1093/rheumatology/keab253.
  • Pekiner FN, Aytugar E, Demirel GY, et al. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with behçet’s disease and recurrent aphthous ulcerations. J Oral Pathol Med. 2012;41(1):73–79. doi:10.1111/j.1600-0714.2011.01061.x.
  • Ahmadi M, Yousefi M, Abbaspour-Aghdam S, et al. Disturbed Th17/treg balance, cytokines, and miRNAs in peripheral blood of patients with behcet’s disease. J Cell Physiol. 2019;234(4):3985–3994. doi:10.1002/jcp.27207.
  • Afzali B, Lombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148(1):32–46. doi:10.1111/j.1365-2249.2007.03356.x.
  • Tian Y, Wang C, Ye Z, et al. Effect of 1,25-Dihydroxyvitamin D3 on Th17 and Th1 response in patients with behçet’s disease. Invest Ophthalmol Vis Sci. 2012;53(10):6434–6441. doi:10.1167/iovs.12-10398.
  • Fernandez Lahore G, Raposo B, Lagerquist M, et al. Vitamin D3 receptor polymorphisms regulate T cells and T cell-dependent inflammatory diseases. Proc Natl Acad Sci U S A. 2020;117(40):24986–24997. doi:10.1073/pnas.2001966117.
  • Martens P-J, Gysemans C, Verstuyf A, et al. Vitamin D’s effect on immune function. Nutrients. 2020;12:1248. doi:10.3390/nu12051248.
  • Ao T, Kikuta J, Ishii M. The effects of vitamin D on immune system and inflammatory diseases. Biomolecules. 2021;11:1624. doi:10.3390/biom11111624.
  • Boonstra A, Barrat FJ, Crain C, et al. 1α,25-Dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J Immunol. 2001;167(9):4974–4980. doi:10.4049/jimmunol.167.9.4974.
  • Vanherwegen A-S, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am. 2017;46(4):1061–1094. doi:10.1016/j.ecl.2017.07.010.
  • Płudowski P, Kos-Kudła B, Walczak M, et al. Guidelines for preventing and treating vitamin D deficiency: a 2023 update in Poland. Nutrients. 2023;15:695. doi:10.3390/nu15030695.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.